Middle East & Africa Nutraceuticals Market is anticipated to observe impressive growth during the forecast period, 2024-2028. The major factors include massive demand from people of all age groups and rapid development in healthcare and pharmaceutical industry. An all-encompassing term, "nutraceutical," refers to substances that are regarded as foods, components of foods, or dietary supplements and may make claims of offering medical or health benefits, including the treatment or prevention of disease. They also include vitamins and naturally occurring substances like ginseng, garlic, and other herbal products like phytochemicals that are derived from plants. As aggressive marketing campaigns are launched, the trend of the market for nutraceuticals' steady growth is anticipated to continue. The trend toward self-medication is significant for nutraceutical products. Consumer attitudes toward healthcare are evolving, and more people are actively managing their own health as opposed to merely accepting recommendations from doctors. The nutraceuticals market has the potential to expand, but there are still difficulties with consumer education and the laws governing claims. Trust in a particular brand is crucial, and the market will expand as large, multinational corporations with positive reputations enter the market. Nutraceuticals emphasize prevention over treatment. Due to their safe therapeutic effects in addition to their nutritional advantages, this category of products has attracted a lot of attention. Numerous life-threatening illnesses, including diabetes, cancer, neurodegenerative disorders, etc., may be avoided by using them. In Additionally, smaller families, changing lifestyles, and working families are a few of the factors pushing people to consider healthy, quick, and easy to prepare food options. This is where the significance of nutraceutical and functional food enters the picture. Supply must increase in order to keep up with rising demand, hence expanding the Middle East & Africa Nutraceuticals Market.
According to the World Bank, Children in urban areas are twice as likely as those in rural areas to be overweight (20% vs. 11%).
Increasing developments in healthcare and pharmacy
According to the World Bank, in 2019, the per capital health expenditure of the Middle East and Africa region was USD00.51 billion.
Increasing Demand from people of all age groups
According to the Social Sciences Research Ethics Committee of the United Arab Emirates University,nutraceuticals usage to improve health is 66.1%, for bodybuilding 9.9%, disease prevention 6.8%, and weight management 5.3%.
Recent Developments
- In November 2022, the Gulf Pharmaceutical Industries announced to launch more than 86 new drugs in clearly defined new therapeutic areas in the upcoming years and is investing in internal R&D to build a strong and sustainable pipeline.
Market Segmentation
Middle East & Africa Nutraceuticals market is segmented into Product Type, Form, Distribution Channel, Application, End User, Country and Competitive Landscape. Based on Product Type, the market is divided into Combination Dietary Supplement, Herbal Supplement, Fish Oil Omega Fatty Acid, Protein, and Others. Based on Form, the market is divided into Tablets, Capsules, Powder, Liquids and Soft Gels. Based on Distribution Channel, the market is divided into Pharmacies and Drug retailers, Supermarkets and Hypermarkets, Online, Others. Based on Application, the market is divided into Energy Weight Management, General Health, Bone Joint Health, Immunity, Others. Based on End User, the market is divided into Children, Adults, Pregnant Females, Geriatric.
Market Players
Bayer Middle East L L C, Pfizer Gulf FZ LLC, Gulf Pharmaceutical Industries P S C, Abbott Laboratories S A, Glanbia Performance Nutrition, Inc, Nestle Middle East FZE, Nutricia Middle East DMCC (Danone), Archer Daniels Midland Company, Cargill Middle East DMCC, NOW Health Group, Inc are some of the leading companies operating in the market.
Attribute | Details |
Base Year | 2022 |
Historic Data | 2018 – 2021 |
Estimated Year | 2023 |
Forecast Period | 2024 – 2028 |
Quantitative Units | Revenue in USD Million, Volume Units and CAGR for 2018-2022 and 2023-2028 |
Report coverage | Revenue forecast, , company share, competitive landscape, growth factors, and trends |
Segments covered | Product Type Form Distribution Channel Application End-user |
Country Scope | |
Key companies profiled | Bayer Middle East LLC, Pfizer Gulf FZ LLC, Gulf Pharmaceutical Industries P S C, Abbott Laboratories S A, Glanbia Performance Nutrition, Inc, Nestle Middle East FZE, Nutricia Middle East DMCC (Danone), Archer Daniels Midland Company, Cargill Middle East DMCC, NOW Health Group, Inc. |
Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |